New approaches to inhibition of activity of HIV integrase

抑制HIV整合酶活性的新方法

• 批准号: LP100100194
• 负责人: Prof Martin Scanlon
• 金额: $ 41.91万
• 依托单位: Monash University
• 依托单位国家: 澳大利亚
• 项目类别: Linkage Projects
• 财政年份: 2011
• 资助国家: 澳大利亚
• 起止时间: 2011-03-04 至 2013-06-30
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/LP100100194
• 关键词: New; approaches; inhibition; activity; HIV

This project aims to assist in the development of novel anti-HIV drugs that will benefit the 17000 Australians and more than 33 million people worldwide who are currently suffering with this terrible disease. The project will utilise state-of-the-art approaches in structure-based drug design to identify and synthesise compounds as leads for the development of anti-HIV drugs. Furthermore, the project will provide invaluable training for the researchers involved and enhance the relationship between the academic and commercial collaborators.

该项目旨在协助开发新型抗艾滋病毒药物，使目前患有这种可怕疾病的17000名澳大利亚人和全球3300多万人受益。该项目将利用基于结构的药物设计的最先进方法来识别和合成化合物，作为开发抗艾滋病毒药物的先导。此外，该项目将为参与研究的研究人员提供宝贵的培训，并加强学术和商业合作者之间的关系。